Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis

MLA

Marco Filetti, et al. “Comparing Efficacy and Safety of Upfront Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Network Meta-Analysis.” Exploration of Targeted Anti-Tumor Therapy, vol. 4, no. 6, Dec. 2023, pp. 1136–44. EBSCOhost, https://doi.org/10.37349/etat.2023.00187.

APA

Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, & Gennaro Daniele. (2023). Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis. Exploration of Targeted Anti-Tumor Therapy, 4(6), 1136–1144. https://doi.org/10.37349/etat.2023.00187

Chicago

Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, and Gennaro Daniele. 2023. “Comparing Efficacy and Safety of Upfront Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Network Meta-Analysis.” Exploration of Targeted Anti-Tumor Therapy 4 (6): 1136–44. doi:10.37349/etat.2023.00187.